Does the addition of chemotherapy to adjuvant endocrine treatment add any benefit in ER-positive early breast cancer: can we rely on large randomized control trials in the era of personalized medicine?

Subjects

Subjects :

*CANCER chemotherapy
*ADJUVANT treatment of cancer
*ENDOCRINE system
*BREAST cancer
*ESTROGEN receptors
*TAMOXIFEN
EDITORIALS

Details

Language :

English

ISSN :

09237534

Volume :

22

Issue :

9

Database :

Academic Search Index

Journal :

Annals of Oncology

Publication Type :

Academic Journal

Accession number :

65092872

Full Text :

https://doi.org/10.1093/annonc/mdr338